BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 36140775)

  • 61. Mosaicism for the full mutation and a microdeletion involving the CGG repeat and flanking sequences in the FMR1 gene in eight fragile X patients.
    Grasso M; Faravelli F; Lo Nigro C; Chiurazzi P; Sperandeo MP; Argusti A; Pomponi MG; Lecora M; Sebastio GF; Perroni L; Andria G; Neri G; Bricarelli FD
    Am J Med Genet; 1999 Jul; 85(3):311-6. PubMed ID: 10398249
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Rare FMR1 gene mutations causing fragile X syndrome: A review.
    Sitzmann AF; Hagelstrom RT; Tassone F; Hagerman RJ; Butler MG
    Am J Med Genet A; 2018 Jan; 176(1):11-18. PubMed ID: 29178241
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Detection of Cryptic Fragile X Full Mutation Alleles by Southern Blot in a Female and Her Foetal DNA via Chorionic Villus Sampling, Complicated by Mosaicism for 45,X0/46,XX/47,XXX.
    Pandelache A; Francis D; Oertel R; Dickson R; Sachdev R; Ling L; Gamage D; Godler DE
    Genes (Basel); 2021 May; 12(6):. PubMed ID: 34073864
    [TBL] [Abstract][Full Text] [Related]  

  • 64. CGG allele size somatic mosaicism and methylation in FMR1 premutation alleles.
    Pretto DI; Mendoza-Morales G; Lo J; Cao R; Hadd A; Latham GJ; Durbin-Johnson B; Hagerman R; Tassone F
    J Med Genet; 2014 May; 51(5):309-18. PubMed ID: 24591415
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mosaicism for an FMR1 gene deletion in a fragile X female.
    Fan H; Booker JK; McCandless SE; Shashi V; Fleming A; Farber RA
    Am J Med Genet A; 2005 Jul; 136(2):214-7. PubMed ID: 15940701
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Site-specific R-loops induce CGG repeat contraction and fragile X gene reactivation.
    Lee HG; Imaichi S; Kraeutler E; Aguilar R; Lee YW; Sheridan SD; Lee JT
    Cell; 2023 Jun; 186(12):2593-2609.e18. PubMed ID: 37209683
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Fragile X syndrome and FMR1-dependent diseases - clinical presentation, epidemiology and molecular background].
    Landowska A; Rzońca S; Bal J; Gos M
    Dev Period Med; 2018; 22(1):14-21. PubMed ID: 29641417
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Qualitative assessment of FMR1 (CGG)n triplet repeat status in normal, intermediate, premutation, full mutation, and mosaic carriers in both sexes: implications for fragile X syndrome carrier and newborn screening.
    Hantash FM; Goos DG; Tsao D; Quan F; Buller-Burckle A; Peng M; Jarvis M; Sun W; Strom CM
    Genet Med; 2010 Mar; 12(3):162-73. PubMed ID: 20168238
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Epigenetics of fragile X syndrome and fragile X-related disorders.
    Kraan CM; Godler DE; Amor DJ
    Dev Med Child Neurol; 2019 Feb; 61(2):121-127. PubMed ID: 30084485
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Genome-wide analysis validates aberrant methylation in fragile X syndrome is specific to the FMR1 locus.
    Alisch RS; Wang T; Chopra P; Visootsak J; Conneely KN; Warren ST
    BMC Med Genet; 2013 Jan; 14():18. PubMed ID: 23356558
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Deletion in the FMR1 gene in a fragile-X male.
    Mannermaa A; Pulkkinen L; Kajanoja E; Ryynänen M; Saarikoski S
    Am J Med Genet; 1996 Aug; 64(2):293-5. PubMed ID: 8844068
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Incomplete silencing of full mutation alleles in males with fragile X syndrome is associated with autistic features.
    Baker EK; Arpone M; Aliaga SM; Bretherton L; Kraan CM; Bui M; Slater HR; Ling L; Francis D; Hunter MF; Elliott J; Rogers C; Field M; Cohen J; Cornish K; Santa Maria L; Faundes V; Curotto B; Morales P; Trigo C; Salas I; Alliende AM; Amor DJ; Godler DE
    Mol Autism; 2019; 10():21. PubMed ID: 31073396
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Maternal FMR1 premutation allele expansion and contraction in fraternal twins.
    Alfaro MP; Cohen M; Vnencak-Jones CL
    Am J Med Genet A; 2013 Oct; 161A(10):2620-5. PubMed ID: 23949867
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Testing the FMR1 promoter for mosaicism in DNA methylation among CpG sites, strands, and cells in FMR1-expressing males with fragile X syndrome.
    Stöger R; Genereux DP; Hagerman RJ; Hagerman PJ; Tassone F; Laird CD
    PLoS One; 2011; 6(8):e23648. PubMed ID: 21909353
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A novel fragile X syndrome mutation reveals a conserved role for the carboxy-terminus in FMRP localization and function.
    Okray Z; de Esch CE; Van Esch H; Devriendt K; Claeys A; Yan J; Verbeeck J; Froyen G; Willemsen R; de Vrij FM; Hassan BA
    EMBO Mol Med; 2015 Apr; 7(4):423-37. PubMed ID: 25693964
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Reciprocal changes in DNA methylation and hydroxymethylation and a broad repressive epigenetic switch characterize FMR1 transcriptional silencing in fragile X syndrome.
    Brasa S; Mueller A; Jacquemont S; Hahne F; Rozenberg I; Peters T; He Y; McCormack C; Gasparini F; Chibout SD; Grenet O; Moggs J; Gomez-Mancilla B; Terranova R
    Clin Epigenetics; 2016; 8():15. PubMed ID: 26855684
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Reversion of FMR1 Methylation and Silencing by Editing the Triplet Repeats in Fragile X iPSC-Derived Neurons.
    Park CY; Halevy T; Lee DR; Sung JJ; Lee JS; Yanuka O; Benvenisty N; Kim DW
    Cell Rep; 2015 Oct; 13(2):234-41. PubMed ID: 26440889
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Intragenic FMR1 disease-causing variants: a significant mutational mechanism leading to Fragile-X syndrome.
    Quartier A; Poquet H; Gilbert-Dussardier B; Rossi M; Casteleyn AS; Portes VD; Feger C; Nourisson E; Kuentz P; Redin C; Thevenon J; Mosca-Boidron AL; Callier P; Muller J; Lesca G; Huet F; Geoffroy V; El Chehadeh S; Jung M; Trojak B; Le Gras S; Lehalle D; Jost B; Maury S; Masurel A; Edery P; Thauvin-Robinet C; Gérard B; Mandel JL; Faivre L; Piton A
    Eur J Hum Genet; 2017 Apr; 25(4):423-431. PubMed ID: 28176767
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A Robust Polymerase Chain Reaction-based Assay for Quantifying Cytosine-guanine-guanine Trinucleotide Repeats in Fragile X Mental Retardation-1 Gene.
    Wang H; Zhu X; Gui B; Cheung WC; Shi M; Yang Z; Kwok KY; Lim R; Pietilä S; Zhu Y; Choy KW
    J Vis Exp; 2019 Sep; (151):. PubMed ID: 31566610
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Loss of the KH1 domain of FMR1 in humans due to a synonymous variant causes global developmental retardation.
    Carion N; Briand A; Cuisset L; Pacot L; Afenjar A; Bienvenu T
    Gene; 2020 Aug; 753():144793. PubMed ID: 32446918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.